-
From the Editor-in-Chief
Synthetic Lethality and Cancer: Aiming an Arrow at Achilles’ HeelInsights about synthetic lethality have been used to develop cancer treatments.
by William G. Nelson, MD, PhD
-
Recognizing AI’s PotentialPathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.
by Stephen Ornes
-
Policy Matters
Putting an End to Cancer Health DisparitiesCancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.
by Michael A. Caligiuri, MD
-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
-
Forward Look
Opening Clinical Trials to HIV-Positive Cancer PatientsIncluding patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.
by Andy Kopsa
-
Forward Look
Lung Cancer Biology Differs by Race, Study ShowsResearch findings could help improve personalized treatments for lung cancer patients.
by Stephen Ornes
-
What Older Patients ValueMany older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.
by Cheryl Platzman Weinstock
-
Omitting ObesityMany cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Measuring Your MovementResearchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.
by Brad Jones
-
Men Less Likely to Get Genetic TestingA study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.
by Cheryl Platzman Weinstock
Ten-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
